drugset
drugset / Trial / NCT05282914

A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

NCT05282914 ↗

Phase 1 Completed 41 enrolled Korea United Pharm. Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A Study to compare pharmacokinetics, pharmacodynamics and safety of UI058 and UIC202004 in healthy subjects

Timeline

Start
2021-02-03
Primary completion
2021-04-14
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject UI058 Unknown — —
Comparator UIC202004 Unknown — —

Indications

gastroesophageal reflux disease